The epidemiology of myelodysplastic syndromes

Area of Science:

• Hematology
• Oncology
• Epidemiology

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• MDS are characterized by ineffective hematopoiesis and are associated with a high risk of transformation to acute myeloid leukemia.
• The incidence and prevalence of MDS are significant, particularly in older populations.

Purpose of the Study:

• To provide an overview of the current understanding of myelodysplastic syndromes.
• To highlight key epidemiological data, including incidence and prevalence in the United States.
• To identify and discuss the primary risk factors associated with MDS development.

Main Methods:

• The study synthesizes reported epidemiological data on MDS incidence and prevalence.
• Risk factors are identified through a review of established literature and clinical observations.
• Patient demographics and clinical presentation, including cytopenias and transfusion needs, are summarized.

Main Results:

• The reported incidence of MDS in the US is 3.4 per 100,000, with over 10,000 new diagnoses annually.
• The estimated prevalence of MDS in the US is approximately 60,000 individuals.
• MDS diagnoses are most common in the seventh and eighth decades of life, with patients often presenting with cytopenias and requiring transfusions.

Conclusions:

• MDS represents a significant health burden, with incidence likely underestimated.
• Advanced age, male gender, prior cytotoxic exposures, and smoking are key risk factors for MDS.
• Understanding these epidemiological factors is crucial for diagnosis, management, and research into MDS.